These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27707078)

  • 21. Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties.
    Miele D; Rossi S; Sandri G; Vigani B; Sorrenti M; Giunchedi P; Ferrari F; Bonferoni MC
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30445668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
    Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
    J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of surfactant and protein at the O/W interface and its effect on colloidal and biological properties of polymeric nanocarriers.
    Del Castillo-Santaella T; Peula-García JM; Maldonado-Valderrama J; Jódar-Reyes AB
    Colloids Surf B Biointerfaces; 2019 Jan; 173():295-302. PubMed ID: 30308454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction and bioactivity evaluation of hepatocyte growth factor-loaded poly (lactic-co-glycolic acid) nanoparticles].
    Xian WJ; Wang XE; Zhang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Feb; 38(2):217-223. PubMed ID: 29502063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication, characterization and properties of DHA-loaded nanoparticles based on zein and PLGA.
    Liu E; Su Z; Yang C; Ji Y; Liu B; Meng X
    Food Chem; 2021 Oct; 360():129957. PubMed ID: 33989879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.
    Quadros HC; Santos LMF; Meira CS; Khouri MI; Mattei B; Soares MBP; de Castro-Borges W; Farias LP; Formiga FR
    Int J Pharm; 2020 Feb; 576():118997. PubMed ID: 31893542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid emulsion as a drug delivery system for breviscapine: formulation development and optimization.
    Wei L; Li G; Yan YD; Pradhan R; Kim JO; Quan Q
    Arch Pharm Res; 2012 Jun; 35(6):1037-43. PubMed ID: 22870813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
    Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
    Girotra P; Singh SK; Kumar G
    Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.
    Takahashi C; Hattori Y; Yagi S; Murai T; Takai C; Ogawa N; Tanemura M; Fuji M; Kawashima Y; Yamamoto H
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():78-83. PubMed ID: 30678968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PLGA-TiO
    Torres-Ramos MI; Martín-Marquez MF; Leal-Moya MDC; Ghotekar S; Sánchez-Burgos JA; Pérez-Larios A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
    Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
    AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles.
    Kennedy PJ; Perreira I; Ferreira D; Nestor M; Oliveira C; Granja PL; Sarmento B
    Eur J Pharm Biopharm; 2018 Jun; 127():366-370. PubMed ID: 29549023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
    Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
    Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
    Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC/QTOF profile and preliminary stability studies of an enriched flavonoid fraction of Cecropia pachystachya Trécul leaves with potential antidepressant-like activity.
    Ortmann CF; Abelaira HM; Réus GZ; Ignácio ZM; Chaves VC; Dos Santos TC; de Carvalho P; Carlessi AS; Bruchchen L; Danielski LG; Cardoso SG; de Campos AM; Petronilho F; Rebelo J; Dos Santos Morais MO; Vuolo F; Dal-Pizzol F; Streck EL; Quevedo J; Reginatto FH
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28370241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.